| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.00B | 3.04B | 3.26B | 3.79B | 3.53B | 3.15B |
| Gross Profit | 414.50M | 408.65M | 399.05M | 449.24M | 426.52M | 350.72M |
| EBITDA | 135.17M | 132.60M | 140.88M | 164.50M | 155.06M | 104.76M |
| Net Income | 74.45M | 71.55M | 77.06M | 89.81M | 88.80M | 10.79M |
Balance Sheet | ||||||
| Total Assets | 1.72B | 1.79B | 1.78B | 2.07B | 1.94B | 1.67B |
| Cash, Cash Equivalents and Short-Term Investments | 124.92M | 126.16M | 185.46M | 36.18M | 37.99M | 62.72M |
| Total Debt | 7.87M | 147.11M | 153.96M | 343.58M | 288.75M | 164.01M |
| Total Liabilities | 802.94M | 879.20M | 854.78M | 1.16B | 1.13B | 940.49M |
| Stockholders Equity | 914.03M | 906.41M | 924.25M | 905.30M | 806.53M | 731.19M |
Cash Flow | ||||||
| Free Cash Flow | 82.42M | 104.06M | 363.09M | -45.75M | -131.20M | 138.58M |
| Operating Cash Flow | 90.73M | 112.35M | 371.65M | -35.77M | -124.35M | 140.94M |
| Investing Cash Flow | -5.56M | -62.39M | 9.04M | -8.26M | -3.72M | 31.93M |
| Financing Cash Flow | -107.22M | -110.91M | -227.77M | 39.53M | 108.11M | -148.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $1.47B | 17.94 | 9.30% | 1.02% | 3.19% | -4.91% | |
69 Neutral | $12.22B | 15.08 | 9.98% | 1.15% | 6.95% | 19.19% | |
67 Neutral | $4.07B | 18.64 | 4.71% | 2.77% | -2.30% | -29.75% | |
64 Neutral | $905.35M | 13.10 | 8.11% | ― | -4.88% | 2.57% | |
64 Neutral | $5.98B | 13.10 | 7.70% | ― | 3.16% | 1.09% | |
62 Neutral | $2.59B | 19.80 | 8.51% | ― | -6.69% | -51.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
The filing excerpt from ScanSource provides only a cross-reference statement indicating that information disclosed in another section is incorporated by reference, without offering substantive details about the company’s operations, the nature of the transaction, or its impact on stakeholders.
The most recent analyst rating on (SCSC) stock is a Hold with a $43.00 price target. To see the full list of analyst forecasts on ScanSource stock, see the SCSC Stock Forecast page.
On December 9, 2025, ScanSource, Inc. held its annual meeting of shareholders, where 90.5% of issued shares were represented. Shareholders approved the election of eight directors, the compensation of named executive officers, and the appointment of Deloitte & Touche LLP as independent auditors for fiscal 2026.
The most recent analyst rating on (SCSC) stock is a Hold with a $43.00 price target. To see the full list of analyst forecasts on ScanSource stock, see the SCSC Stock Forecast page.